The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels

ŞANLI, Yasemin; KUYUMCU, Serkan; ÖZKAN, Zeynep; Kilic, LEYLA; Balik, Emre; TÜRKMEN, Cüneyt; HAS ŞİMŞEK, Duygu; IŞIK, Emine; Asoglu, Oktar; Kapran, Yersu; Adalet, Isik

doi:10.1007/s12149-012-0609-0

The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels

ŞANLI Y., KUYUMCU S., ÖZKAN Z. G., Kilic L., Balik E., TÜRKMEN C., ...Daha Fazla

ANNALS OF NUCLEAR MEDICINE, cilt.26, sa.7, ss.551-558, 2012 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 7
Basım Tarihi: 2012
Doi Numarası: 10.1007/s12149-012-0609-0
Dergi Adı: ANNALS OF NUCLEAR MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.551-558
Anahtar Kelimeler: Colorectal cancer, Recurrence, CEA levels, FDG-PET/CT, POSITRON-EMISSION-TOMOGRAPHY, CARCINOEMBRYONIC ANTIGEN, COMPUTED-TOMOGRAPHY, F-18-FDG PET, RESECTION, IMPACT, METASTASES, SURVIVAL, CT
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Tumor recurrence of colorectal cancers (CRC) is generally followed up by analyses of the serum carcinoembryonic antigen (CEA) levels. However, recent evidence suggests that tumor recurrence can also be visualized by 18F-fluoro-deoxyglucose emission tomography/computed tomography (FDG-PET/CT) in patients with normal CEA levels. We retrospectively evaluated the diagnostic performance of FDG-PET/CT in patients with suspected recurrence of CRC by comparing PET/CT performance in patients with normal CEA levels with PET/CT performance in patients with elevated CEA levels.